Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Sara M Weis
Dwayne G Stupack
David A Cheresh

Cancer cell

Showing results (1-10 of 5) with videos related to

Pageof 1
Sort By:
Cancer Cell|May 5, 2009
Agonizing integrin antagonists?Sara M Weis, Dwayne G Stupack, David A Cheresh
Cancer Cell|December 9, 2008
Suppressing NFAT increases VEGF signaling in hemangiomasLisette M Acevedo, David A Cheresh
Cancer Cell|December 5, 2017
Glut3 Addiction Is a Druggable Vulnerability for a Molecularly Defined Subpopulation of GlioblastomaÉrika Cosset, Sten Ilmjärv, Valérie Dutoit, et al.
Cancer Cell|July 14, 2012
VEGF inhibits tumor cell invasion and mesenchymal transition through a MET/VEGFR2 complexKan V Lu, Jeffrey P Chang, Christine A Parachoniak, et al.
Cancer Cell|June 14, 2011
Receptor tyrosine kinases and TLR/IL1Rs unexpectedly activate myeloid cell PI3kγ, a single convergent point promoting tumor inflammation and progressionMichael C Schmid, Christie J Avraamides, Holly C Dippold, et al.
Pageof 1

Showing results (1-10 of 5) with videos related to

Sort By:
Pageof 1
Cancer Cell|May 5, 2009
Agonizing integrin antagonists?Sara M Weis, Dwayne G Stupack, David A Cheresh
Cancer Cell|December 9, 2008
Suppressing NFAT increases VEGF signaling in hemangiomasLisette M Acevedo, David A Cheresh
Cancer Cell|December 5, 2017
Glut3 Addiction Is a Druggable Vulnerability for a Molecularly Defined Subpopulation of GlioblastomaÉrika Cosset, Sten Ilmjärv, Valérie Dutoit, et al.
Cancer Cell|July 14, 2012
VEGF inhibits tumor cell invasion and mesenchymal transition through a MET/VEGFR2 complexKan V Lu, Jeffrey P Chang, Christine A Parachoniak, et al.
Cancer Cell|June 14, 2011
Receptor tyrosine kinases and TLR/IL1Rs unexpectedly activate myeloid cell PI3kγ, a single convergent point promoting tumor inflammation and progressionMichael C Schmid, Christie J Avraamides, Holly C Dippold, et al.
Pageof 1